Archives of Biochemistry and Biophysics

IFC Author Index
pp. CO2-CO2(1)

Intervention against the Maillard reaction in vivo
pp. 1-15(15)
Author: Monnier V.M.

Enzymatic deglycation of proteins
pp. 16-24(9)
Authors: Wu X.; Monnier V.M.

Intervention strategies to prevent pathogenetic effects of glycated albumin
pp. 25-30(6)
Author: Cohen M.P.

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
pp. 31-40(10)
Author: Thornalley P.J.

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications
pp. 41-49(9)
Authors: Metz T.O.; Alderson N.L.; Thorpe S.R.; Baynes J.W.

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation
pp. 50-54(5)
Authors: Miyata T.; van Ypersele de Strihou C.

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease
pp. 55-62(8)
Authors: Jerums G.; Panagiotopoulos S.; Forbes J.; Osicka T.; Cooper M.

Novel inhibitors of advanced glycation endproducts
pp. 63-79(17)
Authors: Rahbar S.; Figarola J.L.

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
pp. 80-88(9)
Authors: Hudson B.I.; Bucciarelli L.G.; Wendt T.; Sakaguchi T.; Lalla E.; Qu W.; Lu Y.; Lee L.; Stern D.M.; Naka Y.; Ramasamy R.; Yan S.D.; Yan S.F.; D'Agati V.; Schmidt A.M.

Therapeutic potential of breakers of advanced glycation end product-protein crosslinks
pp. 89-96(8)
Authors: Vasan S.; Foiles P.; Founds H.

Conclusions
pp. 97-97(1)